During the past decade, Arizona Oncology Associates, PC - HOPE conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 97 clinical trials were completed, i.e. on average, 80.8% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 54 clinical trials were completed. i.e. 101.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Oncology Associates, PC - HOPE" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Pfizer" with 10 trials sponsored, "Radiation Therapy Oncology Group" with 10 trials sponsored, "US Oncology Research" with 10 trials sponsored and "Novartis Pharmaceuticals" with 10 trials sponsored. Other sponsors include 159 different institutions and companies that sponsored additional 88 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Oncology Associates, PC - HOPE" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 9 trials as a collaborator, "Sanofi" with 5 trials as a collaborator and "Bristol-Myers Squibb" with 4 trials as a collaborator. Other collaborators include 67 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Oncology Associates, PC - HOPE" are "Breast Cancer" (26 trials), "Ovarian Cancer" (16 trials), "Metastatic Breast Cancer" (12 trials), "Prostate Cancer" (9 trials) and "Multiple Myeloma" (8 trials). Many other conditions were trialed in "Arizona Oncology Associates, PC - HOPE" in a lesser frequency.

Most popular intervention types in "Arizona Oncology Associates, PC - HOPE" are "Drug" (191 trials), "Biological" (14 trials), "Other" (10 trials), "Radiation" (10 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Paclitaxel" (14 trials), "Carboplatin" (13 trials), "Pembrolizumab" (12 trials) and "Gemcitabine" (9 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Oncology Associates, PC - HOPE" are 155 trials for "All" genders, 45 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Arizona Oncology Associates, PC - HOPE". undefined are not yet recruiting, 36 are recruiting, 40 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 96 completed trials in Arizona Oncology Associates, PC - HOPE, undefined suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Oncology Associates, PC - HOPE, 20 "Phase 1" clinical trials were conducted, 100 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Arizona Oncology Associates, PC - HOPE has several departments that took part in Clinical trials: "Arizona Oncology Associates-West Orange Grove" - 17 trials, "Arizona Oncology - HOPE Wilmot" - 12 trials, "Arizona Oncology Associates, PC - HAL" - 7 trials, "Arizona Oncology Associates- East Valley Cancer Center" - 4 trials, "Arizona Oncology" - 4 trials, "Arizona Oncol Assoc Dba (Hem Onc Physicians&Extenders) Hope" - 4 trials, "Northern Arizona Hematology & Oncology Associates, AOA" - 2 trials, "Arizona Oncology Associates, PC-Hope,1620 West St. Mary's Road" - 2 trials, "Arizona Oncology Associates, PC-Hope,2070 W. Rudasill Rd." - 2 trials